Topics

Markets & Companies

Expert Interview: Mark Quick, Recipharm

17.10.2020 -

So far, the pharmaceutical industry — including CMOs/CDMOs and CROs — has responded well to the outbreak of the Covid-19 pandemic. However, the coronavirus crisis has...

Markets & Companies

Expert Interview: Peter Halkjaer-Knudsen, Raybow Pharmaceuticals

17.10.2020 -

So far, the pharmaceutical industry — including CMOs/CDMOs and CROs — has responded well to the outbreak of the Covid-19 pandemic. However, the coronavirus crisis has...

Markets & Companies

Expert Interview: Matthew Moorcroft, Lonza

17.10.2020 -

So far, the pharmaceutical industry — including CMOs/CDMOs and CROs — has responded well to the outbreak of the Covid-19 pandemic. However, the coronavirus crisis has...

Markets & Companies

Expert Interview: Alan Walker, Kaneka

16.10.2020 -

So far, the pharmaceutical industry — including CMOs/CDMOs and CROs — has responded well to the outbreak of the Covid-19 pandemic. However, the coronavirus crisis has...

Markets & Companies

Expert Interview: David Zimmermann, Kalexsyn

16.10.2020 -

So far, the pharmaceutical industry — including CMOs/CDMOs and CROs — has responded well to the outbreak of the Covid-19 pandemic. However, the coronavirus crisis has...

Markets & Companies

Expert Interview: Andrew Thompson, J-Star

16.10.2020 -

So far, the pharmaceutical industry — including CMOs/CDMOs and CROs — has responded well to the outbreak of the Covid-19 pandemic. However, the coronavirus crisis has...

Markets & Companies

Expert Interview: Jean-Luc Herbeaux, Hovione

16.10.2020 -

So far, the pharmaceutical industry — including CMOs/CDMOs and CROs — has responded well to the outbreak of the Covid-19 pandemic. However, the coronavirus crisis has...

Markets & Companies

Expert Interview: GianMarco Negrisoli, Flamma

16.10.2020 -

So far, the pharmaceutical industry — including CMOs/CDMOs and CROs — has responded well to the outbreak of the Covid-19 pandemic. However, the coronavirus crisis has...